metoprolol has been researched along with Innate Inflammatory Response in 15 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Carvedilol and N-acetyl cysteine (NAC) combination decreases inflammation, oxidative stress, and postoperative atrial fibrillation (POAF) rates more than metoprolol or carvedilol." | 9.19 | Oxidative status, inflammation, and postoperative atrial fibrillation with metoprolol vs carvedilol or carvedilol plus N-acetyl cysteine treatment. ( Akcay, S; Ceyhan, BM; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, O; Sutcu, R; Uysal, BA; Varol, E; Yucel, H, 2014) |
| "Metoprolol exerts a disruptive action on neutrophil dynamics during exacerbated inflammation, resulting in an infarct-limiting effect not observed with atenolol or propranolol." | 7.96 | Metoprolol exerts a non-class effect against ischaemia-reperfusion injury by abrogating exacerbated inflammation. ( Clemente-Moragón, A; Fuster, V; García-Prieto, J; Gómez, M; Ibáñez, B; Lalama, DV; Martínez, F; Oliver, E; Sánchez-Cabo, F; Villena-Gutiérrez, R, 2020) |
| "This study evaluated the effects of early treatment with β-adrenergic blocker metoprolol on ventricular remodeling and function after acute myocardial infarction (AMI) by using high frequency ultrasound." | 7.78 | High-frequency ultrasound evaluation of effects of early treatment with metoprolol on myocardial inflammatory cytokine expression in rats with acute myocardial infarction. ( Gao, Y; Huang, L; Wu, W; Yang, Y; Zhang, J, 2012) |
| "Plasma concentrations after oral administration of the high extraction drug propranolol are increased in patients and animals with inflammation." | 7.67 | Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat. ( Belpaire, FM; Bogaert, MG; Chindavijak, B; de Smet, F; Fraeyman, N, 1989) |
| "Metoprolol treatment attenuated vessel positive remodeling and reduced vulnerability index (1." | 5.35 | Effect of metoprolol on vulnerable plaque in rabbits by changing shear stress around plaque and reducing inflammation. ( Changjiang, L; Guihua, J; Huixia, L; Liang, C; Mei, Z; Runyi, S; Xiaobo, H; Xiaojun, C; Xiaonan, L; Xinsheng, X; Yanen, Z; Yun, Z, 2009) |
| "To investigate the changes of inflammatory cytokines in cardiac pacing patients with atrial fibrillation and asymptomatic atrial fibrillation and the effects of metoprolol on them." | 5.27 | Inflammatory cytokines in cardiac pacing patients with atrial fibrillation and asymptomatic atrial fibrillation. ( Kong, F; Lin, J; Pan, J; Wang, W; Wu, X; Zhang, M, 2018) |
| "Carvedilol and N-acetyl cysteine (NAC) combination decreases inflammation, oxidative stress, and postoperative atrial fibrillation (POAF) rates more than metoprolol or carvedilol." | 5.19 | Oxidative status, inflammation, and postoperative atrial fibrillation with metoprolol vs carvedilol or carvedilol plus N-acetyl cysteine treatment. ( Akcay, S; Ceyhan, BM; Dogan, A; Erdogan, D; Icli, A; Okutan, H; Ozaydin, M; Peker, O; Sutcu, R; Uysal, BA; Varol, E; Yucel, H, 2014) |
| "Metoprolol exerts a disruptive action on neutrophil dynamics during exacerbated inflammation, resulting in an infarct-limiting effect not observed with atenolol or propranolol." | 3.96 | Metoprolol exerts a non-class effect against ischaemia-reperfusion injury by abrogating exacerbated inflammation. ( Clemente-Moragón, A; Fuster, V; García-Prieto, J; Gómez, M; Ibáñez, B; Lalama, DV; Martínez, F; Oliver, E; Sánchez-Cabo, F; Villena-Gutiérrez, R, 2020) |
| "This study evaluated the effects of early treatment with β-adrenergic blocker metoprolol on ventricular remodeling and function after acute myocardial infarction (AMI) by using high frequency ultrasound." | 3.78 | High-frequency ultrasound evaluation of effects of early treatment with metoprolol on myocardial inflammatory cytokine expression in rats with acute myocardial infarction. ( Gao, Y; Huang, L; Wu, W; Yang, Y; Zhang, J, 2012) |
| "Plasma concentrations after oral administration of the high extraction drug propranolol are increased in patients and animals with inflammation." | 3.67 | Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat. ( Belpaire, FM; Bogaert, MG; Chindavijak, B; de Smet, F; Fraeyman, N, 1989) |
| "Fibrinogen and WBC were independent predictors of CV death or non-fatal MI as well as disease progression leading to revascularization in patients with stable angina pectoris." | 2.69 | Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm. ( Björkander, I; Forslund, L; Håkan Wallén, N; Held, C; Hjemdahl, P; Rehnqvist, N; Wiman, B, 2000) |
| "Other comorbidities included bronchial asthma, chronic sinusitis, ischemic heart disease, mild aortic stenosis, arterial hypertension, and degenerative thoracic spine disease." | 1.72 | Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis. ( Bergler-Czop, B; Frątczak, A; Miziołek, B; Polak, K, 2022) |
| "Metoprolol pretreatment reduced hepatic expression of proinflammatory cytokines and lowered plasma interleukin-6 (both p < ." | 1.36 | Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats. ( Ackland, GL; Dyson, A; Gourine, AV; Poputnikov, D; Rudiger, A; Singer, M; Stidwill, R; Yao, ST, 2010) |
| "Metoprolol treatment attenuated vessel positive remodeling and reduced vulnerability index (1." | 1.35 | Effect of metoprolol on vulnerable plaque in rabbits by changing shear stress around plaque and reducing inflammation. ( Changjiang, L; Guihua, J; Huixia, L; Liang, C; Mei, Z; Runyi, S; Xiaobo, H; Xiaojun, C; Xiaonan, L; Xinsheng, X; Yanen, Z; Yun, Z, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (20.00) | 29.6817 |
| 2010's | 6 (40.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Frątczak, A | 1 |
| Polak, K | 1 |
| Miziołek, B | 1 |
| Bergler-Czop, B | 1 |
| Clemente-Moragón, A | 1 |
| Gómez, M | 1 |
| Villena-Gutiérrez, R | 1 |
| Lalama, DV | 1 |
| García-Prieto, J | 1 |
| Martínez, F | 1 |
| Sánchez-Cabo, F | 1 |
| Fuster, V | 1 |
| Oliver, E | 1 |
| Ibáñez, B | 1 |
| Heusch, G | 1 |
| Kleinbongard, P | 1 |
| Zhang, K | 1 |
| Tang, YD | 1 |
| Zhang, Y | 1 |
| Ojamaa, K | 1 |
| Li, Y | 1 |
| Saini, AS | 1 |
| Carrillo-Sepulveda, MA | 1 |
| Rajagopalan, V | 1 |
| Gerdes, AM | 1 |
| Pan, J | 2 |
| Wang, W | 1 |
| Wu, X | 1 |
| Kong, F | 1 |
| Lin, J | 1 |
| Zhang, M | 1 |
| Ozaydin, M | 1 |
| Peker, O | 1 |
| Erdogan, D | 1 |
| Akcay, S | 1 |
| Yucel, H | 1 |
| Icli, A | 1 |
| Ceyhan, BM | 1 |
| Sutcu, R | 1 |
| Uysal, BA | 1 |
| Varol, E | 1 |
| Dogan, A | 1 |
| Okutan, H | 1 |
| Liang, C | 1 |
| Xiaonan, L | 1 |
| Xiaojun, C | 1 |
| Changjiang, L | 1 |
| Xinsheng, X | 1 |
| Guihua, J | 1 |
| Xiaobo, H | 1 |
| Yanen, Z | 1 |
| Runyi, S | 1 |
| Huixia, L | 1 |
| Yun, Z | 1 |
| Mei, Z | 1 |
| Ackland, GL | 1 |
| Yao, ST | 1 |
| Rudiger, A | 1 |
| Dyson, A | 1 |
| Stidwill, R | 1 |
| Poputnikov, D | 1 |
| Singer, M | 1 |
| Gourine, AV | 1 |
| Sisakian, AS | 1 |
| Davtian, AR | 1 |
| Pepoian, SK | 1 |
| Oganesian, AS | 1 |
| Wu, W | 1 |
| Huang, L | 1 |
| Zhang, J | 1 |
| Gao, Y | 1 |
| Yang, Y | 1 |
| Huang, CC | 1 |
| Chen, PC | 1 |
| Huang, CW | 1 |
| Yu, J | 1 |
| Schneider, RE | 1 |
| Bishop, H | 1 |
| Kendall, MJ | 1 |
| Quarterman, CP | 1 |
| Held, C | 1 |
| Hjemdahl, P | 1 |
| Håkan Wallén, N | 1 |
| Björkander, I | 1 |
| Forslund, L | 1 |
| Wiman, B | 1 |
| Rehnqvist, N | 1 |
| Belpaire, FM | 2 |
| de Smet, F | 1 |
| Chindavijak, B | 1 |
| Fraeyman, N | 1 |
| Bogaert, MG | 2 |
| Mugabo, P | 1 |
| Rosseel, MT | 1 |
4 trials available for metoprolol and Innate Inflammatory Response
| Article | Year |
|---|---|
Inflammatory cytokines in cardiac pacing patients with atrial fibrillation and asymptomatic atrial fibrillation.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Atrial Fibrillation; C-Reactive Protein; Cytokines; | 2018 |
Oxidative status, inflammation, and postoperative atrial fibrillation with metoprolol vs carvedilol or carvedilol plus N-acetyl cysteine treatment.
Topics: Acetylcysteine; Aged; Antihypertensive Agents; Atrial Fibrillation; Carbazoles; Cardiac Surgical Pro | 2014 |
[The influence of beta-adrenoblocking therapy on the markers of systemic inflammation in patients with acute coronary syndrome].
Topics: Acute Coronary Syndrome; Adrenergic beta-1 Receptor Antagonists; Aged; Biomarkers; C-Reactive Protei | 2011 |
Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris. Results from the APSIS study. The Angina Prognosis Study in Stockholm.
Topics: Adrenergic beta-Agonists; Aged; Angina Pectoris; beta-Thromboglobulin; Calcium Channel Blockers; Car | 2000 |
11 other studies available for metoprolol and Innate Inflammatory Response
| Article | Year |
|---|---|
Torasemide-induced Vascular Purpura in the Course of Eosinophilic Granulomatosis with Polyangiitis.
Topics: Adolescent; Aged; Antibodies, Antineutrophil Cytoplasmic; Antibodies, Antinuclear; Antihypertensive | 2022 |
Metoprolol exerts a non-class effect against ischaemia-reperfusion injury by abrogating exacerbated inflammation.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Humans; Inflammation; Metoprolol; Mice; Myocardial I | 2020 |
Is metoprolol more cardioprotective than other beta-blockers?
Topics: Adrenergic beta-Antagonists; Humans; Inflammation; Metoprolol; Reperfusion Injury | 2020 |
Comparison of Therapeutic Triiodothyronine Versus Metoprolol in the Treatment of Myocardial Infarction in Rats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Echocardiography; Ele | 2018 |
Effect of metoprolol on vulnerable plaque in rabbits by changing shear stress around plaque and reducing inflammation.
Topics: Abdomen; Adrenergic beta-Antagonists; Animals; Aorta; Atherosclerosis; Cytokines; Gene Expression Re | 2009 |
Cardioprotection, attenuated systemic inflammation, and survival benefit of beta1-adrenoceptor blockade in severe sepsis in rats.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Animals; Atenolol; Cytokines; H | 2010 |
High-frequency ultrasound evaluation of effects of early treatment with metoprolol on myocardial inflammatory cytokine expression in rats with acute myocardial infarction.
Topics: Animals; Cytokines; Inflammation; Male; Metoprolol; Myocardial Infarction; Myocardium; Rats; Rats, S | 2012 |
Aristolochic Acid induces heart failure in zebrafish embryos that is mediated by inflammation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Aristolochic Acids; Cyclooxygenase 2; Cyclooxygen | 2007 |
Effect of inflammatory disease on plasma concentrations of three beta-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Proteins; Blood Sedimentation; Female; Humans; Infla | 1981 |
Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol, and antipyrine in the rat.
Topics: Administration, Oral; Animals; Antipyrine; Inflammation; Injections, Intravenous; Male; Metoprolol; | 1989 |
Binding to serum alpha 1-acid glycoprotein and effect of beta-adrenoceptor antagonists in rats with inflammation.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Heart Rate; Inflammation; Injections, Intravenous; M | 1986 |